Hollings Cancer Center Varenicline Sampling Study
| Status: | Recruiting |
|---|---|
| Conditions: | Smoking Cessation, Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/23/2018 |
| Start Date: | December 3, 2018 |
| End Date: | June 2020 |
| Contact: | Lisa L Coles |
| Email: | colesl@musc.edu |
| Phone: | 843-876-2291 |
A Pilot Translational Study of Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation
The purpose of this study is to learn what happens when people are given a free, 4-week,
sample of varenicline, a smoking cessation medication. Investigators will look at quit
attempts, changes in smoking, and attitude towards varenicline, in both smokers who want to
quit and those who do not.
Smoking use causes a number of deaths and diseases, including heart disease and cancer. All
smokers are advised to quit. Varenicline (sometimes called Chantix), is a prescription
medication approved by the US FDA. Many studies show that use of varenicline can help smokers
quit smoking.
Varenicline is a prescription medication, which usually means that people have to see a
doctor to get it. This study examines a different way to deliver varenicline, delivered
directly to participants for a few weeks, and without need to see a doctor. This method is
called "varenicline sampling."
The study is sponsored by the Hollings Cancer Center at the Medical University of South
Carolina. The study is being done at the Medical University of South Carolina, but study
recruitment is based state-wide, throughout South Carolina.
sample of varenicline, a smoking cessation medication. Investigators will look at quit
attempts, changes in smoking, and attitude towards varenicline, in both smokers who want to
quit and those who do not.
Smoking use causes a number of deaths and diseases, including heart disease and cancer. All
smokers are advised to quit. Varenicline (sometimes called Chantix), is a prescription
medication approved by the US FDA. Many studies show that use of varenicline can help smokers
quit smoking.
Varenicline is a prescription medication, which usually means that people have to see a
doctor to get it. This study examines a different way to deliver varenicline, delivered
directly to participants for a few weeks, and without need to see a doctor. This method is
called "varenicline sampling."
The study is sponsored by the Hollings Cancer Center at the Medical University of South
Carolina. The study is being done at the Medical University of South Carolina, but study
recruitment is based state-wide, throughout South Carolina.
Inclusion Criteria:
- age 18+
- daily smoker (25+ days/previous month)
- smoking 5+ cigarettes/day;
- smoking > 1yr;
- some interest in eventual quitting (>2 on 10-point scale);
- has a primary care doctor and has seen that doctor at least once in past year; and
- own a smartphone or have regular (daily) access/use of email.
Exclusion Criteria:
- reports of history of seizures or seizure disorders;
- suicidal ideation in past month;
- any lifetime suicide attempt;
- currently pregnant, breastfeeding, or planning to become pregnant; or
- reports of hallucinations.
We found this trial at
1
site
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
